Test Bank for Ruppel’s Manual of Pulmonary Function Testing
12th Edition, By Mottram
Chapter 1 - 13 Updated
,Chapter 1: Indications for Pulmonary Function Testing Test Bank
MULTIPLE CHOICE
1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson
ANS: D
Hutchinson popularized the concept of using VC to assess lung function, and the names he
gave to several other lung compartments are still used today.
DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None
2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Spirometry cannot assess severity of restriction; for that you need to measure lung volumes (
see Box 1-2, Chapter 1).
DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None
3. The main indication for the measurement of lung volumes is to do which of the following?
a. Diagnose or assess the severity of restriction.
b. Evaluate the severity of pulmonary hypertension.
c. Determine the level of cardiopulmonary fitness.
d. Assess the risk of abdominal surgical procedures.
ANS: A
The most common reason for measuring lung volumes is to identify restrictive lung
disease. DIF: 1 REF: p. 35 OBJ: EL-2 MSC: NBRC: None
4. DLCO measurements may be indicated to evaluate pulmonary involvement in which of
the following systemic diseases?
,Stuvia.com - The Marketplace to Buy and Sell your Study Material
a. Asthma
b. Sarcoidosis
c. Exertional hypoxemia
d. Guillain-Barré syndrome
ANS: B
Sarcoidosis is the only systemic disease listed that affects gas exchange.
DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 OBJ: EL-2 MSC: NBRC: None
5. Blood gas analysis is used with patients with COPD to do which of the
following?
a. Monitor airway responsiveness.
b. Determine level of cardiopulmonary fitness.
c. Detect pulmonary hypertension.
d. Assess need for supplementary O2.
ANS: D
Blood gas analysis is most commonly used to determine the need for supplemental oxygen
and to manage patients who require ventilatory support.
DIF: 2 REF: p. 15 OBJ: EL-1
MSC: NBRC: CPFT 2A-2
6. Which of the following cause emphysema?
1. 1- Antitrypsin deficiency
2. Exposure to environmental pollutants
3. Radiation therapy
4. Cigarette smoking
a. 1 and 2
b. 3 and 4
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Emphysema is caused primarily by cigarette smoking. Some emphysema is caused by the
absence of a protective enzyme. Chronic exposure to environmental pollutants can also
contribute to the development of emphysema.
DIF: 1 REF: p. 11 OBJ: EL-3 | AL-2 MSC: NBRC: None
7. An adult patient complains of chest tightness and cough whenever he jogs in cold
weather. These symptoms are consistent with which of the following?
a. Cystic fibrosis
b. Asthma
c. Pulmonary hypertension
d. Idiopathic pulmonary fibrosis
|
, ANS: fB
Agents for fevents fthat fcause fan fasthmatic fepisode fare fcalled ftriggers f(see fBox f1-7,
fChapter f1). fAntigens fsuch fas fanimal fdander, fpollens, fand fdusts fare fthe fmost fcommon
ftriggers. fOther fcommon ftriggers finclude fexposure fto fair fpollutants fand fexercise fin
fcold for fdry fair.
DIF: 2 REF: p. f16 OBJ: EL-3 MSC: fNBRC: fNone
8. Which fof fthe ffollowing fstatements fconcerning ftumors fin fthe fupper fairway fis ftrue?
a. There fmay fbe fvariable for ffixed fobstruction.
b. Fixed fobstruction fwill fbe fpresent.
c. Variable fobstruction fwill fbe fpresent.
d. Small fairway fobstruction fwill fresult.
ANS: fA
Tumors finvolving fthe fupper fairway fmay fcause fvariable for ffixed fobstruction.
DIF: 2 REF: p. f19 OBJ: EL-2
fMSC: fNBRC: fCPFT f3C-3
9. Sarcoidosis fis fa fsystemic fdisorder fthat fusually fcauses fwhich fof fthe ffollowing?
a. A frestrictive fventilatory fdefect
b. An fobstructive fventilatory fdefect
c. Hyperreactive fairways
d. Primary fpulmonary fhypertension
ANS: fA
Restriction fis foften fassociated fwith fthe ffollowing: finterstitial flung fdiseases, fincluding
fidiopathic ffibrosis, fpneumoconioses, fand fsarcoidosis.
DIF: 1 REF: p. f19 f| fp. f21 OBJ: EL-3 MSC: fNBRC: fNone
10. For fwhich fof fthe ffollowing fconditions fmight fpulmonary ffunction ftesting fbe
fcontraindicated?
a. Vocal fcord fdysfunction
b. Untreated fpneumothorax
c. Congestive fheart ffailure f(CHF)
d. Bronchiolitis fobliterans
ANS: fB
Pulmonary ffunction ftests fare fusually fcontraindicated fin fthe fpresence fof fpneumothorax.
fHowever, fundiagnosed fpneumothorax fmay fpresent fa frisk fif fpulmonary ffunction fstudies
fare fperformed.
DIF: 1 REF: p. f23 OBJ: EL-4
fMSC: fNBRC: fCPFT f2B-6
d.
11. Which fof fthe ffollowing fcorrectly fdescribe(s) fappropriate fphysical fmeasurements
fbefore fpulmonary ffunction ftesting?
12th Edition, By Mottram
Chapter 1 - 13 Updated
,Chapter 1: Indications for Pulmonary Function Testing Test Bank
MULTIPLE CHOICE
1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson
ANS: D
Hutchinson popularized the concept of using VC to assess lung function, and the names he
gave to several other lung compartments are still used today.
DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None
2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Spirometry cannot assess severity of restriction; for that you need to measure lung volumes (
see Box 1-2, Chapter 1).
DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None
3. The main indication for the measurement of lung volumes is to do which of the following?
a. Diagnose or assess the severity of restriction.
b. Evaluate the severity of pulmonary hypertension.
c. Determine the level of cardiopulmonary fitness.
d. Assess the risk of abdominal surgical procedures.
ANS: A
The most common reason for measuring lung volumes is to identify restrictive lung
disease. DIF: 1 REF: p. 35 OBJ: EL-2 MSC: NBRC: None
4. DLCO measurements may be indicated to evaluate pulmonary involvement in which of
the following systemic diseases?
,Stuvia.com - The Marketplace to Buy and Sell your Study Material
a. Asthma
b. Sarcoidosis
c. Exertional hypoxemia
d. Guillain-Barré syndrome
ANS: B
Sarcoidosis is the only systemic disease listed that affects gas exchange.
DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 OBJ: EL-2 MSC: NBRC: None
5. Blood gas analysis is used with patients with COPD to do which of the
following?
a. Monitor airway responsiveness.
b. Determine level of cardiopulmonary fitness.
c. Detect pulmonary hypertension.
d. Assess need for supplementary O2.
ANS: D
Blood gas analysis is most commonly used to determine the need for supplemental oxygen
and to manage patients who require ventilatory support.
DIF: 2 REF: p. 15 OBJ: EL-1
MSC: NBRC: CPFT 2A-2
6. Which of the following cause emphysema?
1. 1- Antitrypsin deficiency
2. Exposure to environmental pollutants
3. Radiation therapy
4. Cigarette smoking
a. 1 and 2
b. 3 and 4
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Emphysema is caused primarily by cigarette smoking. Some emphysema is caused by the
absence of a protective enzyme. Chronic exposure to environmental pollutants can also
contribute to the development of emphysema.
DIF: 1 REF: p. 11 OBJ: EL-3 | AL-2 MSC: NBRC: None
7. An adult patient complains of chest tightness and cough whenever he jogs in cold
weather. These symptoms are consistent with which of the following?
a. Cystic fibrosis
b. Asthma
c. Pulmonary hypertension
d. Idiopathic pulmonary fibrosis
|
, ANS: fB
Agents for fevents fthat fcause fan fasthmatic fepisode fare fcalled ftriggers f(see fBox f1-7,
fChapter f1). fAntigens fsuch fas fanimal fdander, fpollens, fand fdusts fare fthe fmost fcommon
ftriggers. fOther fcommon ftriggers finclude fexposure fto fair fpollutants fand fexercise fin
fcold for fdry fair.
DIF: 2 REF: p. f16 OBJ: EL-3 MSC: fNBRC: fNone
8. Which fof fthe ffollowing fstatements fconcerning ftumors fin fthe fupper fairway fis ftrue?
a. There fmay fbe fvariable for ffixed fobstruction.
b. Fixed fobstruction fwill fbe fpresent.
c. Variable fobstruction fwill fbe fpresent.
d. Small fairway fobstruction fwill fresult.
ANS: fA
Tumors finvolving fthe fupper fairway fmay fcause fvariable for ffixed fobstruction.
DIF: 2 REF: p. f19 OBJ: EL-2
fMSC: fNBRC: fCPFT f3C-3
9. Sarcoidosis fis fa fsystemic fdisorder fthat fusually fcauses fwhich fof fthe ffollowing?
a. A frestrictive fventilatory fdefect
b. An fobstructive fventilatory fdefect
c. Hyperreactive fairways
d. Primary fpulmonary fhypertension
ANS: fA
Restriction fis foften fassociated fwith fthe ffollowing: finterstitial flung fdiseases, fincluding
fidiopathic ffibrosis, fpneumoconioses, fand fsarcoidosis.
DIF: 1 REF: p. f19 f| fp. f21 OBJ: EL-3 MSC: fNBRC: fNone
10. For fwhich fof fthe ffollowing fconditions fmight fpulmonary ffunction ftesting fbe
fcontraindicated?
a. Vocal fcord fdysfunction
b. Untreated fpneumothorax
c. Congestive fheart ffailure f(CHF)
d. Bronchiolitis fobliterans
ANS: fB
Pulmonary ffunction ftests fare fusually fcontraindicated fin fthe fpresence fof fpneumothorax.
fHowever, fundiagnosed fpneumothorax fmay fpresent fa frisk fif fpulmonary ffunction fstudies
fare fperformed.
DIF: 1 REF: p. f23 OBJ: EL-4
fMSC: fNBRC: fCPFT f2B-6
d.
11. Which fof fthe ffollowing fcorrectly fdescribe(s) fappropriate fphysical fmeasurements
fbefore fpulmonary ffunction ftesting?
